Christus Health Selects Micromedex Evidence-Based Drug, Disease Support System: Ann Arbor-based Truven Health Analytics, formerly the health care business of Thomson Reuters, today announced that Christus Health, a 30 hospital, 5,000-bed organization based in Houston, Texas and operating in seven states, has completed a multi-year agreement for broad access to Truven’s Micromedex Clinical Knowledge Suite for evidence-based Drug, Toxicology, Disease, Neonatal and Pediatric clinical resources and tools. With this agreement, Christus Health clinical staff in 22 facilities will now have unlimited access to their Micromedex Solution. A single solution for clinicians, such as nurses, physicians and pharmacists, Micromedex provides evidence-based clinical content like drug interactions, poisonous substance identification, patient-specific disease treatment options and Pediatric dosing information to help care-givers make informed and confident patient safety, medication, and care management decisions. Micromedex evidence-based resources are impeccably sourced, referenced in context, rigorously reviewed and updated, and are the industry standard for completeness and comprehensiveness. In the last 12 months, approximately eight million searches of clinical content resources have been conducted by clinicians and healthcare professionals in healthcare systems and hospitals, pharmaceutical and Industrial organizations around the globe in the Micromedex 2.0 platform alone. Truven Health Micromedex Solutions will be available to Christus Health staff via the Internet from a computer or tablet, anywhere in the hospital, at any time. More at www.truvenhealth.com.